Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1

Por Desai, Tanvi J., Toombs, Jason E., Minna, John D., Brekken, Rolf A., Udugamasooriya, Damith Gomika
Publicado no Oncotarget (2016)

Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib

Por Kirane, Amanda, Toombs, Jason E, Larsen, Jill E, Ostapoff, Katherine T, Meshaw, Kathryn R, Zaknoen, Sara, Brekken, Rolf A, Burrows, Francis J
Publicado em 2012

Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

Por Kirane, Amanda, Toombs, Jason E., Ostapoff, Katherine, Carbon, Juliet G., Zaknoen, Sara, Braunfeld, Jordan, Schwarz, Roderich E., Burrows, Francis J., Brekken, Rolf A.
Publicado em 2012

Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation

Por Vijay, Rahul, Guthmiller, Jenna J., Sturtz, Alexandria J., Crooks, Sequoia, Johnson, Jordan T., Li, Lei, Lan, Linda Yu-Ling, Pope, Rosemary L., Chen, Yani, Rogers, Kai J., Dutta, Nirmal, Toombs, Jason E., Wilson, Mary E., Wilson, Patrick C., Maury, Wendy, Brekken, Rolf A., Butler, Noah S.
Publicado no J Exp Med (2021)

Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer

Por Huang, Huocong, Zhang, Yuqing, Gallegos, Valerie, Sorrelle, Noah, Zaid, Mohamed Medhat, Toombs, Jason, Du, Wenting, Wright, Steven, Hagopian, Moriah, Wang, Zhaoning, Hosein, Abdel Nasser, Sathe, Adwait Amod, Xing, Chao, Koay, Eugene J, Driscoll, Kyla E, Brekken, Rolf A
Publicado no EMBO Mol Med (2019)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes

Por Weston, Philip S.J., Paterson, Ross W., Modat, Marc, Burgos, Ninon, Cardoso, Manuel J., Magdalinou, Nadia, Lehmann, Manja, Dickson, John C., Barnes, Anna, Bomanji, Jamshed B., Kayani, Irfan, Cash, David M., Ourselin, Sebastien, Toombs, Jamie, Lunn, Michael P., Mummery, Catherine J., Warren, Jason D., Rossor, Martin N., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Publicado no Alzheimers Dement (Amst) (2015)

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

Por Paterson, Ross W., Slattery, Catherine F., Poole, Teresa, Nicholas, Jennifer M., Magdalinou, Nadia K., Toombs, Jamie, Chapman, Miles D., Lunn, Michael P., Heslegrave, Amanda J., Foiani, Martha S, Weston, Philip S. J., Keshavan, Ashvini, Rohrer, Jonathan D., Rossor, Martin N., Warren, Jason D., Mummery, Catherine J., Blennow, Kaj, Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Publicado no Alzheimers Res Ther (2018)

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non Small Cell Lung Cancer

Por Kim, Hyun Seok, Mendiratta, Saurabh, Kim, Jiyeon, Pecot, Chad Victor, Larsen, Jill E., Zubovych, Iryna, Seo, Bo Yeun, Kim, Jimi, Eskiocak, Banu, Chung, Hannah, McMillan, Elizabeth, Wu, Sherry, De Brabander, Jef, Komurov, Kakajan, Toombs, Jason E., Wei, Shuguang, Peyton, Michael, Williams, Noelle, Gazdar, Adi F., Posner, Bruce A., Brekken, Rolf, Sood, Anil K., Deberardinis, Ralph J., Roth, Michael G., Minna, John D., White, Michael A.
Publicado em 2013